Pencil Biosciences
6 known investors
Find your way into Pencil Biosciences
Sign up to see every warm intro you have to Pencil Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pencil Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pencil Biosciences develops a fully synthetic, modular, non-CRISPR gene editing platform that edits DNA without causing a break or nick. The technology targets applications in therapeutics and cell line engineering.
Investors · 6
EMV Capitallisted by EMV CapitalLondon
How we know: EMV Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
Future Planet Capitallisted by Future Planet CapitalLondon
How we know: Future Planet Capital's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Northern Gritstonelisted by Northern GritstoneManchester
How we know: Northern Gritstone's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Pencil Biosciences do?
- Pencil Biosciences develops a fully synthetic, modular, non-CRISPR gene editing platform that edits DNA without causing a break or nick. The technology targets applications in therapeutics and cell line engineering.
- Who are Pencil Biosciences's investors?
- Pencil Biosciences's investors include EMV Capital, Future Planet Capital, Martlet Capital, Northern Gritstone, Octopus Ventures, UK Innovation & Science Seed Fund.




